Complete Response Letters
LEO Pharma A/S: tralokinumab
What FDA's Complete Response Letters to the company say, in the letters' own words.
Complete Response Letter, Apr 23, 2021
You also provided additional information in your Late-Cycle background package dated January 22, 2021, where you asserted that @ 3 510(k) FDA cleared medical device that is manufactured ]
CRL_BLA761180_20210423:p1:s20More Complete Response Letters
Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.